Speaker: Dr. Marcelo A. Wood – Thur 10/25 @4:00pm (UCI)

Beyond Your Genes: Biology of Addiction

marceloThe human brain is simply amazing. Understanding how the 86 billion neurons work in our brain is not simple. Those neurons control your body, your actions, and your memories by communicating with one another. In the past decade or so, a new master regulator of neuronal communication has been discovered. Professor Wood will discuss the role of this master regulator in the young brain, how it becomes impaired in the aging brain, and how it is hijacked by drugs of abuse in the addicted brain. He will also discuss how knowledge of this master regulator is leading to the development of new therapeutics for brain disorders.

Marcelo A. Wood, Ph.D.
University of California, Irvine
Chair and Professor
Neurobiology and Behavior

4:00pm at Crystal Cove Auditorium, UCI Student Center

Reserve your spot here!
The event is open to the public and the UCI campus community.
Parking is available for $10 per vehicle at the UCI Student Center Parking Structure.


CABSCon3 Biotech Symposium – Fri 11/09 @9am-5pm (CSUF)

The Center for Applied Biotechnology Studies is holding their 3rd version of the 1-day conference, CABSCon3 on Friday, November 9. Breakfast will be served in the morning, followed by speakers and poster presentations by students during lunch.
It is a great opportunity for students to network and present their work. Registration is free but limited to 100 spots so register soon!

Click here for more information and a link to register!

CABSCon3 Poster v4.pages

Speaker: Dr. Allyson Fry-Petit – Tues 10/09 @4:30pm in Room 410

Designing the materials of tomorrow at the atomic scale: taking the “EUREKA!” moments out of the lab

Fry-PetitPeople picture that scientists are heard shouting “EUREKA!” throughout the week as they find the next ground breaking discovery, however scientists know that the path to said discovery is slow, costly, and wrought with pitfalls. This talk will demonstrate how the Fry-Petit materials chemistry lab combines big data with synthesis and analysis to improve the success rate of experiments. As an example we will present how within one summer this approach has led us to discover three new solids that have potential use in sonar, computer memory, and sensors. Increasing the number of these compounds in the family by 17% in a single experiment a significant improvement over traditional methods.  Details of data mining, solid state synthesis, and diffraction techniques will be presented.

Science Club Meeting – Tues 10/02 @4:30pm in Room 439


Join us this Tuesday as we will be hearing from 3 students from Fullerton College that participated in research internships and other programs. Rosa Serrano (UCI), Kim Lopez (UC Santa Barbara), and Michelle Yoon (NASA) will be talking about what it’s like to participate in these programs, how to find these opportunities, and how to apply for them. We hope to see you there!

Speaker: Dr. Kris Sachsenmeier – Mon 10/01 @4:30pm in Room 410

Drug Development in the Biopharmaceutical Enterprise

Kris Sachsenmeier- Assoc. Director, Translational Science, IMED Oncology
AstraZeneca -Waltham, Massachusetts

Khris SAn overview of drug development will be presented within the context of a biopharmaceutical enterprise.  A specific cancer target and the agents that target will be used as an example.  The entire process, from target discovery through validation, lead discovery and clinical trials will be outlined.  For benefit of students, key differences between academic and industrial science will be discussed.   Topics will include but not be limited to: “How do you find a cancer drug target?” “How do you find a drug?” “How do you test a new drug in the lab?”  “How do you test a drug in people?” “What are the pros and cons of doing science in an academic or industrial setting?”  “What would prepare me for a job in biopharmaceuticals?”

Kris studied at the University of Wisconsin, Madison for both undergraduate and graduate degrees in Biochemistry, Immunology and Toxicology. Next, he studied tumor viruses during a postdoctoral fellowship at the University of Pittsburgh.  Kris then worked in two startup-biotechnology companies: Automated Cell in Pittsburgh and Arius in Toronto.  In both companies, Kris led teams doing anti-cancer antibody discovery. After joining Medimmune, Kris led the first Oncology Research bi-specific antibody project as well as various “Function First” target/lead discovery projects. Recently Kris joined the Translational Sciences team at Astrazeneca.